KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Exchange Rate Effect: 2019-2025

Historic Exchange Rate Effect for Ionis Pharmaceuticals (IONS) over the last 6 years, with Sep 2025 value amounting to -$82,000.

  • Ionis Pharmaceuticals' Exchange Rate Effect fell 123.43% to -$82,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $259,000, marking a year-over-year decrease of 52.30%. This contributed to the annual value of -$273,000 for FY2024, which is 177.56% down from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Exchange Rate Effect of -$82,000 as of Q3 2025, which was down 113.78% from $595,000 recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Exchange Rate Effect registered a high of $595,000 during Q2 2025, and its lowest value of -$486,000 during Q4 2024.
  • For the 3-year period, Ionis Pharmaceuticals' Exchange Rate Effect averaged around $74,909, with its median value being $70,000 (2023).
  • In the last 5 years, Ionis Pharmaceuticals' Exchange Rate Effect crashed by 1,800.00% in 2022 and then spiked by 2,686.96% in 2025.
  • Quarterly analysis of 5 years shows Ionis Pharmaceuticals' Exchange Rate Effect stood at -$68,000 in 2021, then spiked by 902.94% to $546,000 in 2022, then tumbled by 39.56% to $330,000 in 2023, then tumbled by 247.27% to -$486,000 in 2024, then slumped by 123.43% to -$82,000 in 2025.
  • Its last three reported values are -$82,000 in Q3 2025, $595,000 for Q2 2025, and $232,000 during Q1 2025.